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Edited by Veli-Pekka LehtoAbstract We investigated in vivo the chemotherapeutic an-
thracycline agents doxorubicin and its ability to activate
mitochondrial-mediated, receptor-mediated and endoplasmic/
sarcoplasmic reticulum-mediated apoptosis transduction path-
ways in cardiac tissue from male and female rats. We admin-
istered a single low dose of doxorubicin (10 mg/kg of body
weight, i.p.) and then isolated mitochondrial and cytosolic
proteins one and four days later from the heart. Caspase-3
protein content and caspase-3 activity were signiﬁcantly in-
creased after day four of doxorubicin treatment in both male and
female rats. However, while males had DNA fragmentation at
day one but not day four following doxorubicin administration,
females showed no signiﬁcant increase in DNA fragmentation at
either time. Caspase-12, localized in the SR, is considered a
central caspase, and its activation by cleavage via calpain
indicates activation of the SR-mediated pathway of apoptosis.
Cleaved caspase-12 content and calpain activity signiﬁcantly
increased after day four of doxorubicin treatment in both sexes.
In the mitochondrial-mediated pathway, there were no signiﬁcant
treatment eﬀects observed in cytosolic cytochrome c and cleaved
(active) caspase-9 in either sex. In control rats (saline injection),
glutathione peroxidase (GPX) activity and hydrogen peroxide
(H2O2) production were lower in females compared to males.
Doxorubicin treatment did not signiﬁcantly aﬀect H2O2, GPX
activity or ATP production in isolated mitochondria in either
sex. Female rats produced signiﬁcantly lower levels of H2O2
production one day after doxorubicin treatment, whereas male
rats produced signiﬁcantly less mitochondrial H2O2 four days
after doxorubicin treatment. The receptor-mediated pathway
(caspase-8 and c-FLIP) showed no evidence of being signiﬁcantly
activated by doxorubicin treatment. Hence, doxorubicin-induced
apoptosis in vivo is mediated by the SR to a greater extent than
other apoptotic pathways and should therefore be considered for
targeted therapeutic interventions. Moreover, no major sex
diﬀerences exist in apoptosis signaling transduction cascade due
to doxorubicin treatment.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Doxorubicin causes dose-dependent acute and chronic car-
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failure [1,2]. The mechanism of cardiomyopathy remains un-
clear, but reactive oxygen species (oxidants) are likely involved
[3–6]. Furthermore, it is unknown whether sex diﬀerences exist
in doxorubicin-induced cardiotoxicity and in doxorubicin-in-
duced apoptosis and apoptosis signaling transduction cas-
cades. Compelling evidence from several epidemiological and
clinical studies indicates a substantially higher incidence of
heart failure and cardiovascular disease in men compared with
age-matched women [7–9], suggesting that sex diﬀerences in
cardioprotection exist. The biochemical and molecular bases
for these diﬀerences have been attributed in part to increased
estrogen levels and increased telomerase activity [10,11], which
could increase tissue regeneration capacity [12].
Mitochondrial derived oxidants probably play a key role in
triggering doxorubicin toxicity in vitro [13,14]. Isolated heart
mitochondria shuttle single electrons to doxorubicin, giving
rise to oxygen radicals through the autooxidation of adria-
mycin semiquinones [15]. However, mitochondria have excel-
lent adaptive defense systems which have evolved over millions
of years to cope with sudden changes in oxidative challenges
[16,17]. Recently, we found that the mitochondria of doxoru-
bicin-treated (20 mg/kg) male rats show adaptive mechanisms,
including increased antioxidant defenses and increased mito-
chondrial eﬃciencies, with minimal eﬀects on ATP production
[18]. This raises the possibility that hydrogen peroxide (H2O2)
released from the mitochondria may inactivate key proteins
and enzymes present in nearby targets, which could include
cardiac sarcoplasmic reticulum (SR). Protective antioxidant
defense mechanisms of the SR may be incapable of coping
with the sudden increases in H2O2 produced by the mito-
chondria and eﬀect apoptosis signaling [19].
The central signaling component of apoptosis is a proteo-
lytic system involving a family of cysteine proteases called
caspases (cysteine-dependent, aspartate-speciﬁc proteases) lo-
calized in various parts of the cell [20]. Interest in the control of
apoptosis has grown signiﬁcantly, since disturbed apoptosis
may contribute to cardiomyopathies resulting from chronic
use of drugs such as doxorubicin [21,22]. Depending on the
dose of doxorubicin and model system used (i.e., cell culture or
animal model), several pathways of apoptosis have been
implicated in the induction of cell death [2,4,23,24], including
the mitochondrial pathway, the extrinsic receptor-mediated
pathway, and the endoplasmic/sarcoplasmic reticulum (ER/
SR) pathways. In the mitochondrial pathway, mitochondrial
dysfunction can lead to the release of mitochondrial cyto-
chrome c [20,25,26] into the cytoplasm. Cytochrome c, alongation of European Biochemical Societies.
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called the apoptosome that activates caspase-3, a key cell death
protease [27]. Activation of the extrinsic receptor-mediated
pathway leads to activation of procaspase-8, which then
cleaves and activates procaspase-3 to initiate the caspase cas-
cade [28]. Doxorubicin treatment in vitro causes apoptosis via
Fas-mediated activation of caspase-8 [29], but it is not known
whether this occurs in vivo.
Less attention has been paid to the ER/SR-mediated path-
way of apoptosis. The SR, which is a specialized form of the
ER, provides maintenance of optimal calcium (Ca2þ) levels for
proper contractility in cardiac myocytes. Recently, it has been
shown that increased intracellular Ca2þ concentrations sig-
niﬁcantly increase susceptibility to apoptosis via activation of
caspase-12, localized on the cytoplasmic side of the SR [30,31].
Hence, acute and chronic oxidative stress by doxorubicin may
induce apoptosis by SR-mediated caspase-12, in vivo, a pos-
sibility, which has not been investigated.2. Methods
2.1. Animals and doxorubicin treatment
Six-month-old male and female Fisher 344 rats (National Institute of
Aging colony, Harlan Sprague Dawley, Indianapolis, IN) were used in
this study. The animals were housed individually in a temperature (18–
22 C) and light-controlled environment with a 12-h light/dark cycle
and were provided with food and water ad libitum. Animals from both
male (N ¼ 24) and female groups (N ¼ 24) were randomly assigned
either to a control or to a doxorubicin-treated group. Doxorubicin
hydrochloride (Sigma Chemical Co., St. Louis, MO) was dissolved in
saline and administered by intraperitoneal injection at a dose of 10 mg/
kg, while control animals were injected with a comparable volume of
saline. At one day after injection (saline: 6 males and 6 females;
doxorubicin: 6 males and 6 females) and four days after injection
(saline: 6 males and 6 females; doxorubicin: 6 males and 6 females),
animals were sacriﬁced by deep anesthesia with an intraperitoneal in-
jection of sodium pentobarbital (5 mg/100 g body weight) followed by
thoracotomy and removal of blood by cardiac puncture. The entire
heart was then excised, rinsed in saline to remove any remaining blood,
blotted dry, and weighed. All experimental procedures received ap-
proval from the University of Florida’s Institute on Animal Care and
Use Committee.
2.2. Mitochondrial function
Mitochondria were immediately isolated from the left ventricle (500
mg) of the heart as previously described [32]. Brieﬂy, the tissue was
minced on ice in 5 volumes of isolation buﬀer (0.225 M mannitol, 0.075
M sucrose, and 0.2% fatty acid-free bovine serum albumin, pH 7.4),
homogenized on ice in a Potter–Elvehjem glass homogenizer and
centrifuged for 10 min at 700 g at 4 C. The resulting supernatant
was centrifuged again for 10 min at 8000 g at 44 C. The supernatant
(cytosolic fraction) was aliquotted and stored at )80 C. The mito-
chondrial pellet was resuspended in 5 ml of isolation buﬀer and cen-
trifuged for 10 min at 8000 g. The ﬁnal mitochondrial pellet was
resuspended in 1 ml of isolation buﬀer. Mitochondrial O2 consumption
was determined as previously described [33]. ATP production was
measured with ﬁreﬂy luciferase, which ﬂuoresces in proportion to the
presence of ATP, as described previously [34,35]. Mitochondrial H2O2
production rate was measured enzymatically using homovanillic acid
[36]. Protein concentrations were determined by Bradford assay [37].2.3. Western blots analysis of caspase-3, caspase-8, caspase-9, caspase-
12, XIAP, FLIP, Bcl-2, and bax
Cytosolic proteins were separated electrophoretically on a 4–20%
precast polyacrylamide gel (Cambrex, Rockland, ME) and transferred
onto a nitrocellulose membrane (Cambrex). The membranes were
blocked overnight using a blocking solution containing 0.05% Tween
and 5.0% dried milk, incubated for 90 min with primary antibody in
blocking solution, rinsed in PBS buﬀer, incubated for 90 min in anti-rabbit or mouse Ig horseradish peroxidase (Amersham Life Science,
England) [1:1000] and rinsed again. The membranes were then devel-
oped using ECL Western blotting detection reagent (Amersham Phar-
macia Biotech, England) and imaged using a Kodak Image Station
440CF (Eastman Kodak, Rochester, NY). To detect caspases, poly-
clonal antibodies (1:1000 dilution) were used against caspase-3 (full
length), caspase-8 (full length), caspase-9 (cleaved) (all from Stressgen,
Canada), caspase-12 (cleaved), and caspase-12 antibody (cleaved) (both
from Oncogene Research Products, San Diego, CA). Inhibitors of
apoptosis (XIAP, X-linked inhibitor of apoptosis; FLIP, FLICE-like
inhibitory protein) were detected in the cytosolic fraction of the
cardiomyocytes using a monoclonal antibody against XIAP (MBL,
Watertown,MA, 1:500) and antiserumagainst FLIP (Alexis, SanDiego,
CA, 1:1000). Bcl-2 family proteins were detected using polyclonal anti-
bodies against Bax (Ab-1; 1:200) and Bcl-2 (Ab-4; 1:200) (Santa Cruz
Biotechnology, Santa Cruz, CA).
2.4. Measurement of DNA fragmentation
DNA fragmentation was quantiﬁed by measuring the content of
cytosolic mono- and oligo-nucleosomes (180 base pair nucleotides or
multiples) using a Cell Death ELISA kit (Roche Molecular Bio-
chemicals, Germany) that employs the sandwich enzyme immunoassay
technique.
2.5. Caspase-3, calpain, glutathione peroxidase and cytochrome c assays
Caspase-3 activity was measured using the synthetic peptide n-ace-
tyl-DEVD-AMC (BD PharMingen, San Diego, CA). Calpain activity
was measured using a ﬂuorometric assay kit that utilizes the unique
ability of calpain to digest synthetic substrate Suc-LLVY AMC in the
presence of the Ca2þ ion and the reducing agent TCEP (Oncogene).
Selenium-dependent glutathione peroxidase (GPX) activity was as-
sayed according to Nakamura et al. [38] using H2O2 as the substrate.
Cytosolic cytochrome c was quantiﬁed using an ELISA kit that em-
ploys the sandwich enzyme immunoassay technique (R&D Systems
Minneapolis, MN). All assays were measured in triplicate.
2.6. Estrogen (estradiol) levels
Plasma estradiol concentration was measured using a radioimmu-
noassay (Yerkes Endocrine Laboratory, Atlanta, GA).
2.7. Statistical analysis
Two-way ANOVA was used for comparisons between groups.
Bonferroni post-hoc testing was performed if signiﬁcance was found. A
P-value of less than 0.05 was considered statistically signiﬁcant.3. Results
3.1. Body weight and heart weight
The mean body weight of male rats was signiﬁcantly greater
than that of female rats (P < 0:05; Table 1). Male heart weights
were 36% greater than that of females ðP < 0:001Þ, but female
rats had a signiﬁcantly higher heart weight-to-body weight ratio
ðP < 0:001Þ. Body weight was not diﬀerent one day after
doxorubicin treatment in male or female rats. However, there
was a signiﬁcant decrease ()10%) in body weight four days after
doxorubicin treatment in male rats ðP < 0:001Þ, but not in
female rats ()7.7%; P > 0:05), while the heart weights of male
and female rats remained unaltered one day following doxoru-
bicin treatment. In both sexes, there was a signiﬁcant decrease in
heart weight four days after doxorubicin treatment. Males
showed a 15% decrease in heart weight ðP < 0:001Þ and females
showed a slightly smaller decline (13%) ðP < 0:05Þ. The heart
weight-to-body weight ratio in male and female rats was not al-
tered at either time point after doxorubicin treatment (Table 1).3.2. Plasma estrogen levels in male and female rats
Plasma estrogen was only 20–30% higher in male than in
female rats (Table 2; P < 0:05) and there were no diﬀerences
Table 1
Body weight, heart weight, and heart weight-to-body weight ratio of male and female rats treated with doxorubicin or saline
Male Female
Control Dox-day 1 Dox-day 4 Control Dox-day 1 Dox-day 4
Body weight (g) 358.8 31.0 357.2 24.0 323.9 25.0a 197.6 10.0b 190.6 14.0b 176.0 7.0b
Heart weight (g) 0.81 0.07 0.78 0.05 0.69 0.04a 0.52 0.03b 0.51 0.05b 0.45 0.01a ;b
HW/BW ratio 0.0022 0.001 0.0021 0.0008 0.0023 0.0007 0.0026 0.0001b 0.0027 0.0002b 0.0026 0.0009b
Body weight, heart weight, and the heart weight-to-body weight ratio (HW/BW) from male (N ¼ 24) and female rats (N ¼ 24), which were randomly
assigned either to a control (saline injected) or to a doxorubicin-treated group (10 mg/kg body weight). Dox; doxorubicin.
a Signiﬁcantly diﬀerent from saline injected rats ðP < 0:05Þ.
b Signiﬁcant sex diﬀerence ðP < 0:05Þ.
Fig. 1. Sarcoplasmic reticulum-mediated pathway. The eﬀect of
doxorubicin administration on the content of (A) cleaved caspase-12
and (B) cytosolic calpain activity. Animals from both male (N ¼ 24)
and female groups (N ¼ 24) were randomly assigned either to a control
or to a doxorubicin-treated group. Doxorubicin hydrochloride (Sigma)
was dissolved in saline and administered by intraperitoneal injection at
a dose of 10 mg/kg body weight, while control animals were injected
with a comparable volume of saline (See Section 2). Values presented
are meansS.E.M. Signiﬁcantly diﬀerent from control animals
(*P < 0:05).
Table 2
Plasma 17-b estradiol levels of male and female rats treated with
doxorubicin or saline
Control Dox-day 1 Dox-day 4
Male 5.7 0.6 6.0 1.5 6.1 0.7
Female 8.4 2.7a 8.7 2.4a 7.0 1.4a
Plasma estrogen (estradiol; pg/ml) in male (N ¼ 24) and female rats
(N ¼ 24) of randomly assigned control (saline injected) or doxorubi-
cin-treated rats (10 mg/kg) (meanS.E.M.).
a Signiﬁcant sex diﬀerence ðP < 0:05Þ.
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between the individual female rats due to estrous cycle was
approximately 15–25% (average S.E.M. of approximately 2.2
pg/ml) (Table 2).
3.3. Sarcoplasmic reticulum-mediated apoptosis determined by
the activation of caspase-12 and calpain activity
Calpains and caspase-12 are two cysteine protease families
that play important roles in regulating pathological cell death.
There were no diﬀerences in cleaved caspase-12 content or
calpain activity between male and female control rats (Fig. 1A)
or at one day after doxorubicin treatment. However, four days
after doxorubicin treatment there were signiﬁcant increases in
both cleaved caspase-12 content ðP < 0:01Þ and calpain ac-
tivity ðP < 0:05Þ in both male and female rats (Fig. 1B). Cal-
pain activation in cell culture is responsible for cleavage of
procaspase-12 to generate active caspase-12 [39,40]. Hence,
these data suggest that this novel apoptotic pathway involving
calcium-mediated calpain activation and cross talk between
calpain and caspase families exists in vivo.
3.4. Apoptosis, caspase-3 content and activity, and XIAP levels
To assess the incidence of apoptotic cell death, we deter-
mined the levels of mono- and oligo-nucleosomes contents,
cleaved caspase-3 and caspase-3 activity in the isolated cyto-
solic fraction of the heart tissue. Apoptosis is characterized by
the formation of mono- and oligo-nucleosome in the nucleus.
Levels of mono- and oligo-nucleosome were similar in the male
and female control animals (Fig. 2A). However, male rat
hearts contained greater levels of mono- and oligo-nucleosome
content one day after doxorubicin treatment ðP < 0:01Þ with
levels returning to those seen in control animals by day four. In
contrast, female rats showed no changes following doxorubicin
administration, suggesting that female hearts were more re-
sistant to apoptosis.
There were no diﬀerences in caspase-3 proteolytic enzyme
activity between male and female control rats, or at one day
after doxorubicin administration (Fig. 2B). However, fourdays after the administration of doxorubicin there were sig-
niﬁcant increases in caspase-3 activity in both male and female
rats ðP < 0:01Þ. This increase in activity was due to cleavage of
zymogen (pro-caspase-3), because levels of the cleaved active
caspase-3 were signiﬁcantly increased after day four in both
the male and female rats (Fig. 2C). No sex or treatment dif-
ferences were found in the zymogen pro-caspase-3 or X-linked
inhibitor apoptotic protein (XIAP), a repressor of caspase-3
activity (Table 3).
3.5. Mitochondrial-mediated pathway of apoptosis
Apoptosis in cardiac myocytes is often associated with the
release of cytochrome c from the mitochondria and activation
of caspase-9. Female control rats had signiﬁcantly lower cy-
Fig. 3. Mitochondrial-mediated pathway. The eﬀect of doxorubicin
administration (10 mg/kg) on the mitochondrial-mediated pathway of
apoptosis. (A) cytochrome c concentration in the cytosol, (B) cleaved
caspase-9 content, (C) mitochondrial Bcl-2 content and (D) mito-
chondrial Bax content. Values presented are meansS.E.M. Signiﬁ-
cant sex diﬀerence (xP < 0:05). Signiﬁcantly diﬀerent from control
animals (*P < 0:05).
Fig. 2. DNA fragmentation and caspase-3 content and activity. The
eﬀect of doxorubicin administration (10 mg/kg) on (A) the amount of
DNA fragmentation determined by the content of mono- and oligo-
nucleosomes in the heart cytosol, (B) caspase-3 activity measured using
ﬂuorescence ELISA method, and (C) cleaved caspase-3 concentration
determined by Western blot analysis. Values presented are mean-
sS.E.M. Signiﬁcantly diﬀerent from control animals (*P < 0:05) and
(**P < 0:01).
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(Fig. 3A). Doxorubicin did not aﬀect cytosolic cytochrome c in
male or female rats. Cleaved caspase-9 content was not dif-
ferent between male and female rats (Fig. 3B) and was not
aﬀected by doxorubicin treatment, suggesting no detectable
increase in the activation of the mitochondrial-mediated
pathway with this dose of doxorubicin.Table 3
The eﬀects of doxorubicin administration on Pro-caspase-3 and XIAP levels
Male Female
Control Dox-day 1 Dox-day 4 Control Dox-day 1 Dox-day 4
Pro-Caspase-3 176 040 113 210 182 680 117 906 158 106 100 880 154 092 100 178 130 761 98 793 161 284 108 763
XIAP 375 257 155 468 332 515 135 272 341 874 173 804 408 375 164 343 394 945 119 643 480 747 235 776
XIAP, X-linked inhibitor of apoptosis. Male ðN ¼ 24Þ and female rats ðN ¼ 24Þ were randomly assigned to a control (saline injected) or to a
doxorubicin-treated group (10 mg/kg body weight).
Fig. 4. Mitochondrial hydrogen peroxide production and glutathione
peroxidase activity. The eﬀect of doxorubicin administration on heart
(A) mitochondrial hydrogen peroxide (H2O2) production and (B) mi-
tochondrial glutathione peroxidase activity (GPX). Mitochondria were
isolated on day one and day four after the injection of doxorubicin (10
mg/ml) or an equal volume of saline in control animals. Values pre-
sented are meansS.E.M. Signiﬁcantly diﬀerent from the control
group (**P < 0:001) and (*P < 0:05). Signiﬁcant sex diﬀerence
ðxp < 0:05Þ.
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pro-apoptotic protein) were determined in the same isolated
cardiac mitochondria (Fig. 3C and D). There were no diﬀer-
ences in the levels of these proteins due to sex, but Bcl-2 was
increased four days after doxorubicin treatment in the male
and female rats (although the changes were only statistically
signiﬁcant in the male animals). Bax was not signiﬁcantly
diﬀerent between sexes and was not aﬀected by doxorubicin
treatment.
3.6. Hydrogen peroxide production in isolated mitochondria and
hydrogen peroxide scavenging capacity determined by levels
of glutathione peroxidase
In order to measure the rate of reactive oxygen species
production by heart mitochondria, H2O2 formation was
measured immediately after isolation of mitochondria in all
groups (Fig. 4A). Basal H2O2 production was signiﬁcantly
higher in males compared with females ðP ¼ 0:003Þ. Doxoru-
bicin did not change H2O2 production in the male rats after
one day, whereas H2O2 production was signiﬁcantly decreased
after day one in the female rats ðP < 0:05Þ. Males did show a
signiﬁcant drop ðP < 0:001Þ in H2O2 production after day
four, whereas females remained at approximately the same
level as at day one. These data show that female rats produce
less H2O2 and are able to downregulate the production of
these oxidants one day after doxorubicin treatment, whereas
reduced H2O2 production was only seen in male rats four days
after doxorubicin treatment. Male rats had signiﬁcantly higher
levels of GPX activity compared to female rats ðP ¼ 0:001Þ,
which probably reﬂects the chronically higher H2O2 produc-
tion (Fig. 4B). There was no statistically signiﬁcant eﬀect of
doxorubicin treatment on GPX activity.
3.7. Mitochondrial function
Mitochondrial oxygen consumption was measured during
state 4 (no ADP) and state 3 respiration (0.5 mM ADP) in
male and female rats (Table 4). There were no diﬀerences in
state 4 and state 3 oxygen consumption measurements due to
sex or doxorubicin treatment. However, there was a signiﬁcant
sex diﬀerence in ATP production (determined in state 3)
among control rats, with female rats producing signiﬁcantly
less ATP per milligram of protein of isolated mitochondria
ðP ¼ 0:0032Þ. However, ATP production in isolated mito-
chondria was not aﬀected by doxorubicin treatment. The P/O
ratio, which compares the amount of ATP that is phosphor-
ylated with the amount of oxygen consumed, was also not
aﬀected by sex or doxorubicin treatment, suggesting that mi-
tochondria isolated one day and four days after doxorubicin
treatment were able to adapt and show little evidence of oxi-
dative stress.Table 4
The eﬀects of doxorubicin administration on the mitochondrial function of
Male
Control Dox-day 1 Dox-day 4
State 4 VO2 8.4 1.4 3.0 5.1 8.5 2.5
State 3 VO2 42.2 28.6 47.5 26.1 34.6 24.8
ATP 31.8 8.8 38.1 6.8 33.3 8.5
P/O Ratio 1.2 0.4 1.0 0.5 1.5 0.8
State 4 and state 3, nmol oxygen consumption/mg protein/min and ATP pr
ðN ¼ 24Þ were randomly assigned to a control (saline injected) or to a doxor
a Signiﬁcant gender diﬀerence. ðP < 0:05Þ.3.8. Receptor-mediated pathway of apoptosis
Pro-caspase-8 content (Fig. 5A), cleaved caspase-8 (Fig. 5B)
and cFLIP, an inhibitor of caspase-8 activation (Fig. 5C), were
not diﬀerent between male and female rats and were not af-
fected by doxorubicin treatment.4. Discussion
We found that a relatively low pharmacological dose of
doxorubicin selectively aﬀected the SR-mediated pathway of
apoptosis by activating calpain, caspase-12, and caspase-3.
The activation of caspase-3 appears to be largely due to SR-male and female rats treated with doxorubicin or saline
Female
Control Dox-day 1 Dox-day 4
9.4 3.0 7.2 4.8 8.7 3.1
31.8 22.5 25.9 17.2 21.1 6.7
27.8 8.7a 26.8 12.4a 23.4 6.3a
1.3 0.5 0.9 0.3 1.2 0.3
oduction, nmol ATP/mg protein/min. Male ðN ¼ 24Þ and female rats
ubicin-treated group (10 mg/kg). Values presented are meansS.E.M.
Fig. 5. Receptor-mediated pathway. The eﬀect of doxorubicin ad-
ministration (10 mg/kg) on receptor-mediated apoptosis. (A) Content
of procaspase-8, (B) cleaved caspase-8 content and (C) cFLIP content.
Values presented are means S.E.M.
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mediated pathways. The mitochondrial pathways may have
been attenuated by: (1) decreased production of oxidants, (2)
upregulation of Bcl-2 proteins, which may have prevented
cytochrome c release and caspase-9 activation, or (3) mainte-
nance of energy balance (ATP production). The receptor-
mediated cell death pathway appears to play a minor role in
doxorubicin toxicity, since there were no signiﬁcant increases
in caspase-8, suggesting that intrinsic pathways of apoptosis
play a greater role.
We failed to detect any major sex diﬀerences in apoptosis
signaling following doxorubicin treatment. However, we did
ﬁnd less DNA fragmentation after doxorubicin, lower basal
cytosolic cytochrome c levels and lower basal levels of mito-
chondrial H2O2 production in female rats. In our animals,
plasma estrogen levels were in the pg/ml range, which, in
comparison to the much larger concentrations of lipid and
water soluble antioxidants found in the plasma [41], may have
been too low to have any signiﬁcant eﬀect on attenuating ox-
idative stress.In cardiac myocytes, the SR functions as an intracellular
Ca2þ store for use in excitation-contraction coupling. The SR
Ca2þ ATPase (SERCA) pumps Ca2þ into the SR terminal
cisternae, leading to cardiac relaxation [42]. A prolonged dis-
ruption in SR function or SR stress stimulates activation of
caspase-12 [31], which is ubiquitously expressed and, like all
caspases, is synthesized as an inactive proenzyme consisting of
a regulatory prodomain and two catalytic p20 and p10 sub-
units [31,43]. However, unlike other caspases, caspase-12 is
remarkably speciﬁc to insults that elicit SR stress and is not
proteolytically activated by other death stimuli [30]. We show
that caspase-12 activity is increased four days after doxoru-
bicin treatment. Although the molecular mechanisms by which
caspase-12 mediates apoptosis are still unclear, cell culture
studies suggest that it cleaves pro-caspase-9 without the in-
volvement of cytochrome c and apoptosome formation [44]. In
our study, we found that calpain activity was signiﬁcantly in-
creased four days after doxorubicin administration, but we did
not detect any signiﬁcant increases in cleaved caspase-9 in vivo
in male and female rats. Calpain activation is responsible for
cleavage of procaspase-12 to generate active caspase-12 [39,40]
and may be the preferred pathway in vivo. Hence, our data
suggest that this novel apoptotic pathway, which involves
calcium-mediated calpain activation and cross talk between
calpain and caspase families, exists in vivo.
Cytosolic levels of cytochrome c, caspase-9 content, H2O2
production and ATP production showed little change after
doxorubicin treatment, suggesting that the mitochondrial-
mediated pathway was not signiﬁcantly activated. Because the
mitochondrial anti-apoptotic protein Bcl-2 was signiﬁcantly
increased in response to doxorubicin administration four days
after treatment, this may have aﬀected cytochrome c release.
Moreover, because ATP production was not signiﬁcantly af-
fected by doxorubicin treatment, it is likely that little mito-
chondrial damage and oxidative stress occurred in the isolated
mitochondria. This is in agreement with reports that mito-
chondrial DNA damage and damage to respiratory complexes
need to be excessive (i.e., exceeding 50% of its function)
before signiﬁcant decreases in ATP production are observed
[45].
H2O2 production in vitro increases immediately after
doxorubicin treatment [5,15], which is in contrast to our
observation that H2O2 production was unchanged or even
decreased following doxorubicin administration in vivo
(Fig. 6). H2O2 is a stable oxidant and is able to diﬀuse out of
the mitochondria and react with cytosolic and nuclear targets
[46]. Indeed, the occurrence of a Cu/Zn-superoxide dismutase
in the inter-membrane compartment may account for part of
the H2O2 released by mitochondria, contributing to a cyto-
solic steady-state level of this species in the cytosol [46].
Cytosolic H2O2 can transiently target speciﬁc oxidative stress
sensitive proteins on the SR. For example, H2O2 could target
calcium ATPase pumps, such as SERCA located on the
surface of the SR [47], which is more prone to oxidation
compared to other Ca2þ regulatory channel proteins [19].
Mitochondria themselves are very well equipped with anti-
oxidant defense systems, such as MnSOD, GPX, GR and
glutathione. Hence, this adaptation may explain why mito-
chondrial mediated apoptosis was not detected in vivo. The
SR, however, may not have such elaborate defense systems,
as it has evolved in an environment that is less aﬀected by
oxidative processes.
Fig. 6. Proposed scheme of SR mediated apoptosis. Hydrogen per-
oxide is a stable oxidant and diﬀuses out of the mitochondria and
could react with cytosolic and nuclear targets. Hence, cytosolic H2O2
can transiently target speciﬁc oxidative stress sensitive proteins on the
SR. H2O2 could target calcium ATPase pumps, such as SERCA lo-
cated on the surface of the SRs and aﬀect calcium homeostasis. The SR
Ca2þ ATPase (SERCA) pumps Ca2þ into the SR terminal cisternae,
leading to cardiac relaxation [42]. A prolonged disruption in SR
function or SR stress stimulates activation of caspase-12, which is
ubiquitously expressed and, like all caspases, is synthesized as an in-
active proenzyme. Unlike other caspases, caspase-12 is remarkably
speciﬁc to insults that elicit SR stress and is not proteolytically acti-
vated by other death stimuli. We show that caspase-12 activity is
increased four days after doxorubicin treatment. The caspase-12-
mediated SR apoptotic pathway may be a key pathway for
doxorubicin toxicity in vivo, independent of the receptor- or mito-
chondria-mediated apoptotic pathways.
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mRNA level and can also bind to ryanodine receptors in SR
[48,49]. Hence, oxidative damage to calcium regulatory chan-
nel proteins and decreases in gene expression may cause al-
terations in Ca2þ homeostasis and subsequently increase
intracellular calcium level. Sustained increase in intracellular
Ca2þ may activate Ca2þ dependent protease calpain, which
could then degrade key structural proteins such as titin [50]
and other sarcomeric proteins, thereby impairing contractility.
Furthermore, calpain can also cleave caspase-12 and other
caspases to initiate a caspase cascade and apoptosis of
cardiomyocytes [39,40]. These events will signiﬁcantly reduce
the number of functional cardiac cells and ultimately lead to
cardiomyopathy.
Our study also suggests that the receptor-mediated apop-
totic pathway is not aﬀected by sex or this dose of doxorubicin
treatment. Furthermore, no signiﬁcant sex diﬀerences in the
caspase-8 inhibitor, cFLIP, were detected, nor were levels
signiﬁcantly altered by doxorubicin treatment. It appears,
therefore, that this pathway may not play an essential role in
inducing apoptosis in vivo, although it remains possible that
the dose injected in these rats did not induce a suﬃcient stress
response to signiﬁcantly activate this pathway. Therefore,
caspase-12-mediated SR apoptotic pathway may be a key
pathway for doxorubicin toxicity in vivo, independent of the
receptor mediated apoptotic pathways, but may be sensitive tomitochondrial H2O2 production and altered calcium homeo-
stasis.
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